Core Laboratories (NYSE:CLB) Price Target Raised to $15.00

Core Laboratories (NYSE:CLB) had its price target upped by Citigroup from $14.00 to $15.00 in a research note published on Thursday,Benzinga reports. They currently have a sell rating on the oil and gas company’s stock.

Separately, StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $17.25.

Core Laboratories Price Performance

CLB opened at $16.13 on Thursday. The company has a market cap of $755.13 million, a P/E ratio of 24.43, a P/E/G ratio of 0.99 and a beta of 2.38. The company has a 50 day moving average of $17.96 and a two-hundred day moving average of $18.79. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. Core Laboratories has a 52-week low of $13.82 and a 52-week high of $25.13.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. On average, analysts expect that Core Laboratories will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Monday, February 10th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, February 10th. This represents a $0.04 annualized dividend and a yield of 0.25%. Core Laboratories’s dividend payout ratio is presently 6.06%.

Institutional Trading of Core Laboratories

Institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. acquired a new stake in Core Laboratories in the fourth quarter valued at $26,000. Smartleaf Asset Management LLC raised its holdings in Core Laboratories by 173.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after acquiring an additional 1,293 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in Core Laboratories by 2,688.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after acquiring an additional 2,339 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in Core Laboratories by 843.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock valued at $57,000 after acquiring an additional 2,936 shares in the last quarter. Finally, BNP Paribas Financial Markets acquired a new stake in Core Laboratories in the fourth quarter valued at $123,000. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.